SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-060202
Filing Date
2017-02-28
Accepted
2017-02-28 07:02:02
Documents
5
Period of Report
2017-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d340168d8k.htm 8-K 19923
2 EX-99.1 d340168dex991.htm EX-99.1 54705
3 EX-99.2 d340168dex992.htm EX-99.2 8806
4 GRAPHIC g340168g01f69.jpg GRAPHIC 4793
5 GRAPHIC g340168g04a19.jpg GRAPHIC 4956
  Complete submission text file 0001193125-17-060202.txt   98597
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 17644671
SIC: 2836 Biological Products, (No Diagnostic Substances)